Loading clinical trials...
Loading clinical trials...
To evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-r...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Medical University
Collaborators
NCT07042100 · Advanced Solid Tumors
NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more
NCT05687123 · Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm, and more
NCT05856370 · Spinal Deformity, Spinal Degenerative Disorder, and more
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions